• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种稳定水溶液中催产素的新策略:I. 二价金属离子和柠檬酸盐缓冲液的影响。

A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.

机构信息

Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands.

出版信息

AAPS J. 2011 Jun;13(2):284-90. doi: 10.1208/s12248-011-9268-7. Epub 2011 Mar 30.

DOI:10.1208/s12248-011-9268-7
PMID:21448747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085697/
Abstract

In the current study, the effect of metal ions in combination with buffers (citrate, acetate, pH 4.5) on the stability of aqueous solutions of oxytocin was investigated. Both monovalent metal ions (Na(+) and K(+)) and divalent metal ions (Ca(2+), Mg(2+), and Zn(2+)) were tested all as chloride salts. The effect of combinations of buffers and metal ions on the stability of aqueous oxytocin solutions was determined by RP-HPLC and HP-SEC after 4 weeks of storage at either 4°C or 55°C. Addition of sodium or potassium ions to acetate- or citrate-buffered solutions did not increase stability, nor did the addition of divalent metal ions to acetate buffer. However, the stability of aqueous oxytocin in aqueous formulations was improved in the presence of 5 and 10 mM citrate buffer in combination with at least 2 mM CaCl(2), MgCl(2), or ZnCl(2) and depended on the divalent metal ion concentration. Isothermal titration calorimetric measurements were predictive for the stabilization effects observed during the stability study. Formulations in citrate buffer that had an improved stability displayed a strong interaction between oxytocin and Ca(2+), Mg(2+), or Zn(2+), while formulations in acetate buffer did not. In conclusion, our study shows that divalent metal ions in combination with citrate buffer strongly improved the stability of oxytocin in aqueous solutions.

摘要

在本研究中,考察了金属离子与缓冲液(柠檬酸盐、醋酸盐、pH4.5)组合对催产素水溶液稳定性的影响。所有单价金属离子(Na(+)和 K(+))和二价金属离子(Ca(2+)、Mg(2+)和 Zn(2+))均以氯化物盐的形式进行测试。通过 RP-HPLC 和 HP-SEC 测定了在 4°C 或 55°C 下储存 4 周后,缓冲液和金属离子的组合对催产素水溶液稳定性的影响。在醋酸盐或柠檬酸盐缓冲液中添加钠离子或钾离子不会增加稳定性,而在醋酸盐缓冲液中添加二价金属离子也不会增加稳定性。然而,在存在 5 和 10 mM 柠檬酸盐缓冲液的情况下,与至少 2 mM 的 CaCl(2)、MgCl(2)或 ZnCl(2)组合,水溶液中催产素的稳定性得到改善,且取决于二价金属离子的浓度。等温滴定量热测量对稳定性研究中观察到的稳定化效果具有预测性。具有改善稳定性的柠檬酸盐缓冲液配方显示催产素与 Ca(2+)、Mg(2+)或 Zn(2+)之间存在强烈相互作用,而醋酸盐缓冲液配方则没有。总之,本研究表明,二价金属离子与柠檬酸盐缓冲液结合可显著提高催产素在水溶液中的稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/e300406acd18/12248_2011_9268_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/10513747bb88/12248_2011_9268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/574bec60a347/12248_2011_9268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/5206996d28f3/12248_2011_9268_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/fc4da5aecf8d/12248_2011_9268_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/e300406acd18/12248_2011_9268_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/10513747bb88/12248_2011_9268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/574bec60a347/12248_2011_9268_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/5206996d28f3/12248_2011_9268_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/fc4da5aecf8d/12248_2011_9268_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6fa/3085697/e300406acd18/12248_2011_9268_Fig5_HTML.jpg

相似文献

1
A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.一种稳定水溶液中催产素的新策略:I. 二价金属离子和柠檬酸盐缓冲液的影响。
AAPS J. 2011 Jun;13(2):284-90. doi: 10.1208/s12248-011-9268-7. Epub 2011 Mar 30.
2
Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers.稳定水溶液中达巴万星的策略;第 1 节:金属离子和缓冲液的影响。
Pharm Res. 2023 Oct;40(10):2469-2478. doi: 10.1007/s11095-023-03588-9. Epub 2023 Sep 11.
3
A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.一种稳定水溶液中环戊缩宫素的新策略:II. 二价金属离子与柠檬酸盐的组合抑制半胱氨酸介导的分子间反应。
Mol Pharm. 2012 Mar 5;9(3):554-62. doi: 10.1021/mp200622z. Epub 2012 Jan 31.
4
The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex.锌-天冬氨酸-催产素复合物抑制催产素二聚体的形成。
J Pharm Sci. 2013 Jun;102(6):1734-1741. doi: 10.1002/jps.23546. Epub 2013 Apr 15.
5
Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation.天门冬氨酸缓冲液和二价金属离子会影响水溶液中的催产素,并保护其免受降解。
Int J Pharm. 2013 Feb 28;444(1-2):139-45. doi: 10.1016/j.ijpharm.2013.01.051. Epub 2013 Feb 1.
6
Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.稳定水溶液中达巴万星的策略;第 3 节:2-羟丙基-β-环糊精和磷酸盐缓冲液的影响,有无二价金属离子。
Pharm Res. 2023 Aug;40(8):2027-2037. doi: 10.1007/s11095-023-03525-w. Epub 2023 Apr 28.
7
Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.用于测定聚烯烃袋中制备的催产素注射剂稳定性的稳定性指示高效液相色谱法。
Drug Discov Ther. 2012 Feb;6(1):49-54.
8
Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.在柠檬酸盐缓冲制剂中,多肽药物催产素与柠檬酸盐之间形成酰胺和酰亚胺键降解产物。
J Pharm Sci. 2011 Jul;100(7):3018-22. doi: 10.1002/jps.22495. Epub 2011 Jan 25.
9
Stabilization of minodronic acid in aqueous solution for parenteral formulation.用于肠胃外制剂的水溶液中米诺膦酸的稳定性。
Int J Pharm. 2001 Jul 3;222(1):91-9. doi: 10.1016/s0378-5173(01)00704-9.
10
Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions.18-冠-6对催产素在水性缓冲溶液中稳定性的影响。
ACS Omega. 2021 Feb 15;6(8):5805-5811. doi: 10.1021/acsomega.0c06248. eCollection 2021 Mar 2.

引用本文的文献

1
Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions.在水溶液中稳定达巴万星的策略;第2节:含和不含二价金属离子的2-羟丙基-β-环糊精和醋酸盐缓冲液的作用
Pharmaceutics. 2024 Nov 22;16(12):1503. doi: 10.3390/pharmaceutics16121503.
2
Pharmacokinetics and Pharmacodynamics of Rusfertide, a Hepcidin Mimetic, Following Subcutaneous Administration of a Lyophilized Powder Formulation in Healthy Volunteers.健康志愿者皮下注射冻干粉末制剂后,铁调素模拟物鲁司特肽的药代动力学和药效学
Drugs R D. 2024 Dec;24(4):539-552. doi: 10.1007/s40268-024-00497-z. Epub 2024 Nov 15.
3

本文引用的文献

1
Extended stability of oxytocin in common infusion solutions.催产素在常用输液溶液中的稳定性延长。
Int J Pharm Compd. 2006 Mar-Apr;10(2):156-8.
2
Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.多肽中天冬酰胺脱酰胺和天冬氨酸异构化的质谱分析。
Electrophoresis. 2010 Jun;31(11):1764-72. doi: 10.1002/elps.201000027.
3
Stability of protein pharmaceuticals: an update.蛋白质类药物的稳定性:最新进展。
Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.
稳定水溶液中达巴万星的策略;第 3 节:2-羟丙基-β-环糊精和磷酸盐缓冲液的影响,有无二价金属离子。
Pharm Res. 2023 Aug;40(8):2027-2037. doi: 10.1007/s11095-023-03525-w. Epub 2023 Apr 28.
4
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.设计提高治疗性肽在水溶液中稳定性的制剂策略:综述
Pharmaceutics. 2023 Mar 14;15(3):935. doi: 10.3390/pharmaceutics15030935.
5
Stability of Oxytocin Preparations in Malawi and Rwanda: Stabilizing Effect of Chlorobutanol.马拉维和卢旺达的催产素制剂稳定性:氯丁醇的稳定作用。
Am J Trop Med Hyg. 2020 Nov;103(5):2129-2141. doi: 10.4269/ajtmh.20-0255.
6
Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries.用于预防中低收入国家产后出血的卡贝缩宫素热稳定制剂的开发和稳定性。
J Pept Sci. 2018 Jun;24(6):e3082. doi: 10.1002/psc.3082. Epub 2018 Apr 27.
7
17-estradiol upregulates oxytocin and the oxytocin receptor in C2C12 myotubes.17-β-雌二醇上调C2C12肌管中的催产素及催产素受体。
PeerJ. 2017 Mar 30;5:e3124. doi: 10.7717/peerj.3124. eCollection 2017.
8
Rapid Absorption of Dry-Powder Intranasal Oxytocin.鼻内干粉催产素的快速吸收
Pharm Res. 2016 Aug;33(8):1936-44. doi: 10.1007/s11095-016-1929-x. Epub 2016 May 18.
9
Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.用于口腔吸入给药的热稳定催产素干粉制剂。
AAPS PharmSciTech. 2015 Dec;16(6):1299-306. doi: 10.1208/s12249-015-0314-0. Epub 2015 Mar 17.
10
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.用于治疗性肽递送的物理化学与制剂可开发性评估——入门指南
AAPS J. 2015 Jan;17(1):144-55. doi: 10.1208/s12248-014-9688-2. Epub 2014 Nov 15.
Pharm Res. 2010 Apr;27(4):544-75. doi: 10.1007/s11095-009-0045-6. Epub 2010 Feb 9.
4
Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.迈向热稳定的催产素制剂:降解动力学分析及降解产物鉴定
Pharm Res. 2009 Jul;26(7):1679-88. doi: 10.1007/s11095-009-9878-2. Epub 2009 Apr 3.
5
Stabilization of a polypeptide in non-aqueous solvents.多肽在非水溶剂中的稳定性
Int J Pharm. 2008 Mar 3;351(1-2):1-7. doi: 10.1016/j.ijpharm.2007.09.012. Epub 2007 Sep 15.
6
WHO analysis of causes of maternal death: a systematic review.世界卫生组织对孕产妇死亡原因的分析:一项系统综述。
Lancet. 2006 Apr 1;367(9516):1066-1074. doi: 10.1016/S0140-6736(06)68397-9.
7
Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon.胰高血糖素酸性降解过程中天冬氨酸裂解和谷氨酰胺脱酰胺机制的研究。
J Pharm Sci. 2005 Sep;94(9):1912-27. doi: 10.1002/jps.20405.
8
Oxytocin-receptor binding: why divalent metals are essential.催产素受体结合:为何二价金属至关重要。
J Am Chem Soc. 2005 Feb 23;127(7):2024-5. doi: 10.1021/ja046042v.
9
International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.国际协调会议;气候区III和IV注册申请的稳定性数据包;新原料药和制剂的稳定性试验;可获取性。通知。
Fed Regist. 2003 Nov 21;68(225):65717-8.
10
RESPONSES OF NERVE-FREE VESSELS TO VASOACTIVE AMINES AND POLYPEPTIDES.无神经血管对血管活性胺和多肽的反应
Am J Physiol. 1965 Apr;208:748-53. doi: 10.1152/ajplegacy.1965.208.4.748.